Tetra Bio-Pharma Inc.
TBP
Classement en actions
#35445
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Prix de l'action
$0.01851783
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$3.71M
Changement (1 jour)
-0.04%
Changement (1 an)
1,443.15%
Pays
CA
Échange Tetra Bio-Pharma Inc. (TBP)
Catégorie
Healthcare
Historique du rendement du dividende pour Tetra Bio-Pharma Inc. (TBP)
Le rendement du dividende (TTM) de Tetra Bio-Pharma Inc. (symbole boursier : TBP) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Tetra Bio-Pharma Inc. (TBP) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
